Cargando…
Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report
Here we introduced a successful case showing neo-adjuvant chemotherapy followed by radical resection for a borderline resectable unicentric Castleman disease (UCD). This study demonstrated that neo-adjuvant rituximab in combination with cyclophosphamide, epirubicin, vincristine and prednisone (R-CHO...
Autores principales: | Zhuang, Hongkai, Ma, Zuyi, Wu, Yanxia, Yin, Zi, Jian, Zhixiang, Zhang, Chuanzhao, Hou, Baohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799261/ https://www.ncbi.nlm.nih.gov/pubmed/35117662 http://dx.doi.org/10.21037/tcr.2020.02.45 |
Ejemplares similares
-
Resection of unicentric interlobar Castleman disease with following adjuvant radiotherapy
por: Sarana, Bruno, et al.
Publicado: (2017) -
Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection
por: Zhang, Chuanzhao, et al.
Publicado: (2019) -
Complete resection of unicentric Castleman disease in the superior mediastinum: A case report
por: Haro, Akira, et al.
Publicado: (2016) -
Castleman's disease: Laparoscopic resection of unicentric disease in the hepatic hilum: A case report
por: Serpa Carmoma, Frans, et al.
Publicado: (2021) -
Unicentric Castleman Disease and Pheochromocytoma
por: Maia, Rosana, et al.
Publicado: (2022)